A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne (Q48540611)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne |
scientific article |
Statements
1 reference
A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne (English)
1 reference
Robert T Brodell
1 reference
Bethanee J Schlosser
1 reference
Elyse Rafal
1 reference
Darryl Toth
1 reference
Stephen Tyring
1 reference
Albert Wertheimer
1 reference
Nabil Kerrouche
1 reference
Delphine Bucher
1 reference
4 January 2012
1 reference
23
1 reference
1
1 reference
26-34
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference